Analyzing the decisions the pharma industry are taking during the Covid-19 crisis and offering insight on how the industry can prepare to shape future supply chains for long-term resilience
Secure your place at this expert roundtable to find out why technology, sustainability and insurance is driving change in the pharma cold chain landscape as Covid-19 impacts the supply chain
The Covid-19 pandemic is raising questions about the current strength of pharma supply chains. Governments are wrestling to combat the right trade response during escalating economic turmoil and support the pharma industry to adopt a more diverse, cost-effective and accessible supply chain.
The choices we make now could change the pharma supply chain for years to come. In this exclusive pharma logistics expert roundtable, Richard Ettl, CEO at SkyCell, will provide an overview on how the pharma supply chain is starting to adapt during the Covid-19 crisis and how it will shape future industry decision-making.
Together with industry leaders, Ettl will discuss the pressing issue of maintaining a resilient supply chain during the Covid-19 outbreak, how to transport pharma goods quickly and safely to patients, and how implementing new technologies can help tackle challenges presented by an unprecedented and ever-changing crisis.
This webinar will evaluate how the pharma supply chain is adapting to change by understanding:
- Lessons learned, past and present, to ensure a high levels of supply chain performance worldwide
- The main challenges that have transpired during the Covid-19 pandemic for pharma companies and what solutions can be implemented to tackle the crisis
- How methods in technology and sustainability are transferable to ensure pharma supply chains can adapt to become robust and resilient in the long term
Sign up now to secure your free place.
Presenter:
Richard Ettl, CEO at SkyCell
Richard Ettl holds a Bachelor of Arts in Management from the University of Fribourg and attended the Executive Leadership Program at Harvard University and the Stanford University Graduate School of Business. Prior to founding SkyCell, Richard worked for Bobst SA in the company’s production and logistics team. SkyCell is based on a strong set of values – innovation, reliability and sustainability – and has become the third largest pharma container provider in seven years. Richard helped establish the Institute for Value-Based Entrepreneurship (IVE) in Switzerland, which to date has offered business plan creation courses to more than 2500 students.